within Pharmacolibrary.Drugs.ATC.D;

model D03BA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.58 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Collagenase is a proteolytic enzyme used to break down collagen, primarily used in the medical treatment for diseases involving excessive collagen accumulation including Dupuytren's contracture and Peyronie's disease. The drug is administered as a prescription medicine in certain local settings and is available under the trade name Xiaflex. Collagenase is not administered systemically and is not generally absorbed into the systemic circulation.</p><h4>Pharmacokinetics</h4><p>No published systemic pharmacokinetic studies of collagenase exists, as it is administered via local injection with minimal systemic absorption. Therefore, no population pharmacokinetics can be reported.</p><h4>References</h4><ol><li><p>Bhatia, AC, et al., &amp; Gelbard, MK (2020). Human Pharmacokinetics and Safety of Subcutaneous Collagenase Clostridium Histolyticum in Women. <i>Journal of drugs in dermatology : JDD</i> 19(9) 852–856. DOI:<a href=&quot;https://doi.org/10.36849/JDD.2020.10.36849/JDD.2020.5048&quot;>10.36849/JDD.2020.10.36849/JDD.2020.5048</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33026751/&quot;>https://pubmed.ncbi.nlm.nih.gov/33026751</a></p></li><li><p>Kaplan, FT (2011). Collagenase clostridium histolyticum injection for the treatment of Dupuytren&#x27;s contracture. <i>Drugs of today (Barcelona, Spain : 1998)</i> 47(9) 653–667. DOI:<a href=&quot;https://doi.org/10.1358/dot.2011.47.9.1656502&quot;>10.1358/dot.2011.47.9.1656502</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21971540/&quot;>https://pubmed.ncbi.nlm.nih.gov/21971540</a></p></li><li><p>Chung, E, et al., &amp; Wang, J (2020). A state-of-art review on collagenase . <i>Expert opinion on biological therapy</i> 20(6) 559–564. DOI:<a href=&quot;https://doi.org/10.1080/14712598.2020.1744558&quot;>10.1080/14712598.2020.1744558</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32345061/&quot;>https://pubmed.ncbi.nlm.nih.gov/32345061</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D03BA02;
